Use of intravesical thiotepa in superficial bladder tumours.
D000287:Administration, Topical; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy*; D013852:Thiotepa / Q000008:administration & dosage*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D013852:Thiotepa